2025-07-14 Drugs SFDA Suspends European Pharmaceutical Factory Due to Critical Manufacturing Violations
2025-07-10 Drugs The SFDA Approves the Registration of “Winrevair” for the Treatment of Pulmonary Arterial Hypertension under the Orphan Drug Designation Pathway